Can You Catch Hepatitis A from a Handshake, But Not Hepatitis B the Same Way?
Sarah, a 34-year-old accountant, sat in my office convinced she’d contracted hepatitis from shaking hands with a sick coworker. She was partially right to worry—and partially wrong. The three hepatitis viruses spread differently, cause different problems in your liver, and require completely different prevention strategies. Yet most people lump them together as one disease. They’re not. Understanding which virus you’re dealing with changes everything about how your doctor treats you and what your long-term health looks like.
Key Facts About Hepatitis
- Hepatitis A infects approximately 4,000 people annually in the United States, with 90-95% of cases in those under age 50 fully recovering without chronic disease.
- Hepatitis B chronically infects about 850,000 to 2.2 million Americans, according to CDC estimates, with 15-25% developing cirrhosis or liver cancer within 20-30 years if untreated.
- Hepatitis C currently affects roughly 2.4 million people in the U.S., but direct-acting antivirals now cure 95%+ of cases with just 8-12 weeks of oral medication.
- Hepatitis A spreads through fecal-oral contamination, making it the only one preventable through improved sanitation and vaccination, with zero chronic carriers.
- Hepatitis B and C create chronic infections in 5-10% and 55-85% of infected adults respectively, making screening critical for anyone with risk factors.
Understanding Hepatitis: What’s Actually Happening Inside Your Liver
Your liver is essentially your body’s chemical processing plant. It filters your blood, breaks down medications, manufactures proteins, stores vitamins, and produces bile to digest fats. When a hepatitis virus invades, it hijacks your liver cells and turns them into viral factories. Think of it like a manufacturing plant where the machinery starts producing the wrong product—except the wrong product damages the facility itself.
Hepatitis A is like a temporary factory shutdown. The virus causes acute inflammation, your immune system ramps up and fights back hard, and usually within weeks the virus is cleared completely. No residual damage, no chronic infection.
Hepatitis B and C are different beasts. In some people, the immune system doesn’t eliminate the virus completely. The virus persists, your liver cells stay inflamed year after year, and that chronic inflammation gradually scars the liver tissue—a process called fibrosis. Over decades, fibrosis becomes cirrhosis, where the liver loses its ability to function. That’s why screening matters so much for these two.
Causes and Risk Factors: The Real Transmission Routes
Hepatitis A spreads through contaminated food or water, which is why shellfish harvested from polluted waters, food prepared by infected people with poor hygiene, and travel to countries with poor sanitation carry higher risk. You can’t get it from sex or blood exposure—the virus needs the fecal-oral route.
Hepatitis B spreads through blood and body fluids. Unprotected sex with an infected partner, sharing needles during drug use, and needle-stick injuries in healthcare settings are the primary routes. Healthcare workers actually have lower risk than people think—post-exposure prophylaxis with hepatitis B immunoglobulin and vaccination works well. Mothers can transmit it to infants during birth, though that’s become rare in developed countries with routine newborn screening.
Hepatitis C almost exclusively spreads through blood-to-blood contact. Current and former injection drug users account for the largest portion of new cases. Blood transfusions before 1992 were a major source—that’s why anyone who received a transfusion before routine screening began should be tested, even if they feel fine. Sexual transmission is possible but uncommon. Here’s the overlooked factor: people who share personal items that might cause microscopic cuts—toothbrushes, razors, nail clippers—can theoretically transmit hepatitis C, though transmission this way is rare.
Signs and Symptoms: What Patients Actually Notice
Hepatitis A usually announces itself. Within 2-7 weeks of exposure, people develop fatigue that feels like you’ve been hit by a truck, right-sided abdominal pain (your liver is enlarged and tender), nausea, loss of appetite, and jaundice—yellowing of the skin and eyes from bilirubin buildup. Urine darkens to tea-colored, stools turn pale. Fever is common. Most people feel acutely, undeniably ill.
Hepatitis B is sneakier. Many newly infected people have no symptoms at all. If symptoms appear, they mimic hepatitis A—fatigue, joint pain, abdominal discomfort, jaundice. But here’s what matters: in children infected at birth, 90% develop chronic infection with almost no symptoms for years. They feel fine. That’s dangerous because they’re silently developing liver damage.
Hepatitis C is the stealth infection. Roughly 80% of newly infected people have zero symptoms. Some experience mild fatigue or abdominal discomfort weeks or months later, then feel better. They think they’re fine. Meanwhile, the virus establishes chronic infection in about 70% of them. This is why the CDC now recommends one-time hepatitis C screening for all adults, not just high-risk groups—you cannot tell by feeling whether you’re infected.
One warning sign people miss: in chronic liver disease from hepatitis B or C, the earliest signs often aren’t abdominal at all. Some patients report unexplained weight loss, easy bruising (your liver makes clotting factors), or changes in thinking and concentration (early hepatic encephalopathy). These creep up slowly.
Diagnosis: What the Tests Actually Tell You
For hepatitis A, your doctor orders anti-HAV IgM antibody testing. This antibody appears during acute infection and disappears within 6 months. If it’s positive, you have acute hepatitis A. If anti-HAV IgG is positive without IgM, you’ve recovered and have immunity.
Hepatitis B diagnosis involves three main tests: HBsAg (hepatitis B surface antigen—indicates current infection), anti-HBs (antibody against surface antigen—indicates immunity from vaccination or recovery), and anti-HBc (core antibody—indicates either current or past infection). If HBsAg is positive for more than 6 months, you have chronic hepatitis B. Your doctor also checks HBeAg and HBV DNA levels to assess how actively the virus is replicating.
Hepatitis C diagnosis starts with anti-HCV antibody screening. If positive, your doctor orders HCV RNA testing to confirm active infection—antibodies can stick around after viral clearance, so RNA testing distinguishes current infection from resolved disease. Then they do genotyping because different hepatitis C genotypes respond differently to treatment.
Once infection is confirmed, your doctor needs to assess liver damage. This means checking liver enzymes (AST, ALT), bilirubin, albumin, and prothrombin time. Many patients now get transient elastography—a painless ultrasound-based test that measures liver stiffness, indicating fibrosis stage. Liver biopsy used to be standard but is rarely done anymore.
Treatment Options: What Actually Works Now
Hepatitis A has no specific antiviral treatment. You get supportive care—rest, fluids, monitor liver function, avoid hepatotoxic substances like alcohol and certain medications. Most cases resolve within 6 weeks without intervention. Rarely, acute liver failure develops; those patients may need transplantation.
Hepatitis B treatment depends on whether you have chronic infection and how much liver damage exists. If your HBV DNA is very high and your liver shows significant inflammation, your doctor usually starts nucleos(t)ide reverse transcriptase inhibitors. Tenofovir (TDF or TAF) and entecavir are first-line choices. These oral medications suppress viral replication—they don’t cure, but they stop the liver damage from progressing. You typically take them indefinitely. Some patients achieve HBeAg seroconversion, meaning the virus stops actively replicating, and your doctor might try stopping treatment. But most patients need lifelong therapy.
Hepatitis C treatment is genuinely transformative now. Direct-acting antivirals—medications like sofosbuvir, daclatasvir, and velpatasvir—actually cure most people. The treatment duration depends on genotype and whether you have cirrhosis, but typical regimens last 8-12 weeks. The SVR (sustained virologic response) rate—meaning virus is undetectable at 12 weeks post-treatment—reaches 95-99% depending on the regimen. This is one of medicine’s success stories. If you have hepatitis C, modern treatment makes cure realistic.
Practical Daily Management: Concrete Strategies
If you have acute hepatitis A, rest genuinely matters—avoid strenuous exercise while your liver is inflamed, which can worsen pain and fatigue. Eat small, frequent meals of bland foods; your inflamed digestive system handles them better. Avoid alcohol and acetaminophen entirely; your liver can’t process them safely. Stay hydrated with water and electrolyte solutions. Most people return to normal activity within 4-6 weeks.
For chronic hepatitis B, regular monitoring is non-negotiable. See a hepatologist or gastroenterologist every 6-12 months for lab work and ultrasound screening for hepatocellular carcinoma—if cirrhosis develops, cancer risk becomes real. Avoid all hepatotoxic substances: alcohol should be eliminated, herbal supplements require careful review (some damage livers), and illicit drugs are dangerous. If you’re on antivirals, adherence is crucial; missed doses can lead to resistance. Vaccinate close contacts against hepatitis A and B if they’re not immune.
For hepatitis C, if you’re treated, your main task is completing the full treatment course and confirming cure with SVR testing. Even after cure, attend follow-up visits to assess for liver scarring; early cirrhosis can be present despite viral clearance, and screening for hepatocellular carcinoma matters if cirrhosis exists. If you have advanced fibrosis, alcohol avoidance becomes especially critical.
Prevention: What the Evidence Actually Shows Works
Hepatitis A prevention is straightforward: vaccination. Two doses of inactivated hepatitis A vaccine, given 6-12 months apart, provides lifelong immunity in over 95% of people. Anyone without prior immunity should get vaccinated, especially those traveling to endemic areas, people with chronic liver disease from other causes, and men who have sex with men. Additionally, proper sanitation—handwashing after bathroom use, safe food preparation—dramatically reduces transmission.
Hepatitis B prevention requires vaccination (similar schedule, extremely effective), plus practicing safe behaviors. Use condoms consistently. Don’t share needles, toothbrushes, or razors. If you work in healthcare, strict bloodborne pathogen precautions matter. Infants now receive routine hepatitis B vaccination at birth; this approach has nearly eliminated hepatitis B in younger generations.
Hepatitis C has no vaccine—prevention relies entirely on avoiding blood exposure. If you use injection drugs, use sterile needles every time (needle exchange programs exist in most cities), never share equipment. Healthcare workers and people with multiple sexual partners should understand their risk. Post-exposure prophylaxis doesn’t exist for hepatitis C like it does for HIV, so prevention is truly critical.
Common Misconception: “I Got Hepatitis B From Casual Contact”
This is medically inaccurate. Hepatitis B does not transmit through saliva, sharing food, coughing, sneezing, hugging, or casual contact. You cannot catch hepatitis B from a toilet seat, doorknob, or shared utensils. Yet I regularly have patients convinced they contracted it this way. The virus requires direct blood-to-blood or body fluid exposure. This misconception causes unnecessary anxiety and sometimes leads people to isolate themselves from family members unnecessarily. If you have hepatitis B and live with unvaccinated people, they should be vaccinated,
